The Old and the New in Prekallikrein Deficiency: Historical Context and a Family from Argentina with PK Deficiency due to a New Mutation (Arg541Gln) in Exon 14 Associated with a Common Polymorphysm (Asn124Ser) in Exon 5

Antonio Girolami; Josè Vidal; Marcela Salagh; Nora Gervan; Maria Parody; Edoardo Peroni; Luisa Sambado; Hugo Guglielmone

doi:10.1055/s-0034-1384767

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2014; 40(05): 592-599
DOI: 10.1055/s-0034-1384767

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Old and the New in Prekallikrein Deficiency: Historical Context and a Family from Argentina with PK Deficiency due to a New Mutation (Arg541Gln) in Exon 14 Associated with a Common Polymorphysm (Asn124Ser) in Exon 5^[*]

Antonio Girolami

¹Department of Medicine, University of Padua Medical School, Padua, Italy

,

Josè Vidal

²Department of Clinical Biochemistry and San Roque Hospital, Faculty of Chemical Sciences, National University of Cordoba, Cordoba, Argentina

,

Marcela Salagh

²Department of Clinical Biochemistry and San Roque Hospital, Faculty of Chemical Sciences, National University of Cordoba, Cordoba, Argentina

,

Nora Gervan

²Department of Clinical Biochemistry and San Roque Hospital, Faculty of Chemical Sciences, National University of Cordoba, Cordoba, Argentina

,

Maria Parody

²Department of Clinical Biochemistry and San Roque Hospital, Faculty of Chemical Sciences, National University of Cordoba, Cordoba, Argentina

,

Edoardo Peroni

¹Department of Medicine, University of Padua Medical School, Padua, Italy

,

Luisa Sambado

¹Department of Medicine, University of Padua Medical School, Padua, Italy

,

Hugo Guglielmone

²Department of Clinical Biochemistry and San Roque Hospital, Faculty of Chemical Sciences, National University of Cordoba, Cordoba, Argentina

› Author Affiliations

Abstract

Prekallikrein (PK) is one of the clotting factors involved in the contact phase of blood. PK has an important historical role as its deficiency state represents the second instance of a clotting defect without bleeding manifestations, the first one being factor XII deficiency. PK deficiency is a rare clotting disorder. Moreover, only 11 patients have been investigated so far by molecular biology techniques. In this article, we briefly review some of the history around PK and also present some recent data on a newly identified family from Argentina suffering from PK deficiency. Two patients are homozygous whereas other family members are heterozygous. PK activity and antigen are 1% of normal in the homozygotes and around 60 to 70% of normal in the heterozygotes. As expected, all patients are asymptomatic of bleeding or thrombosis presentations. However, the two homozygotes showed essential hypertension. The PK deficiency in this family is due to a new mutation (Arg541Gln) in exon 14. The defect segregates together with a known polymorphism, Asn124Ser, in exon 5. The significance of the presence of hypertension in the two homozygotes is discussed in view of the extra coagulation effects of PK on vasodilation, vessel permeability, and the control of blood pressure. Structure function analysis indicates that the substitution of Arg with Gln probably impedes the transmembrane diffusion of the molecule, which therefore cannot be secreted in the homozygotes. The presence of hypertension in patients with PK deficiency has been previously reported in some but not all patients. Future research activities will probably concentrate on the effect of PK and other contact phase factors on the vascular system.

Keywords

prekallikrein deficiency - contact phase - hypertension - blood coagulation

Full Text

References

References
1 Hathaway WE, Belhasen LP, Hathaway HS. Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood 1965; 26 (5) 521-532
2 Girolami A, Scarparo P, Candeo N, Lombardi AM. Congenital prekallikrein deficiency. Expert Rev Hematol 2010; 3 (6) 685-695
3 Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest 1955; 34 (4) 602-613
4 Colman RW. Contact Activation (Kallikrein-Kinin) pathway: Involving inflammatory, fibrinolytic, anticoagulant physiologic and pathophisiologic activities. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, , eds. Hemostasis and Thrombosis, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 107-130
5 Hattersley PG, Hayse D. Fletcher factor deficiency: a report of three unrelated cases. Br J Haematol 1970; 18 (4) 411-416
6 Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) 1983; 62 (4) 248-255
7 Wuillemin WA, Furlan M, von Felten A, Lämmle B. Functional characterization of a variant prekallikrein (PK Zürich). Thromb Haemost 1993; 70 (3) 427-432
8 Bouma BN, Kerbiriou DM, Baker J, Griffin JH. Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency. J Clin Invest 1986; 78 (1) 170-176
9 Lombardi AM, Sartori MT, Cabrio L, Fadin M, Zanon E, Girolami A. Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr). Thromb Haemost 2003; 90 (6) 1040-1045
10 Shigekiyo T, Fujino O, Kanagawa Y, Matsumoto T. Prekallikrein (PK) Tokushima: PK deficiency caused by a Gly401—>Glu mutation. J Thromb Haemost 2003; 1 (6) 1314-1316
11 François D, Trigui N, Leterreux G , et al. Severe prekallikrein deficiencies due to homozygous C529Y mutations. Blood Coagul Fibrinolysis 2007; 18 (3) 283-286
12 Wynne Jones D, Russell G, Allford SL , et al. Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation. Br J Haematol 2004; 127 (2) 220-223
13 Katsuda I, Maruyama F, Ezaki K, Sawamura T, Ichihara Y. A new type of plasma prekallikrein deficiency associated with homozygosity for Gly104Arg and Asn124Ser in apple domain 2 of the heavy-chain region. Eur J Haematol 2007; 79 (1) 59-68
14 Maak B, Kochhan L, Heuchel P, Jenderny J. Severe prekallikrein deficiency due to a compound heterozygosis in the KLKB1-gene [in German]. Hamostaseologie 2009; 29 (2) 187-189
15 Nakao T, Yamane T, Katagami T , et al. Severe prekallikrein deficiency due to a homozygous Trp499Stop nonsense mutation. Blood Coagul Fibrinolysis 2011; 22 (4) 337-339
16 Girolami A, Marun S, Vettore S , et al. A large family from Argentina with prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): prekallikrein Cordoba. Am J Hematol 2010; 85 (5) 363-366
17 Dasanu CA, Alexandrescu DT. A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage. Am J Med Sci 2009; 338 (5) 429-430
18 Nagaya S, Morishita E, Takami A , et al. An elderly case of congenital prekallikrein deficiency [in Japanease]. Nippon Ronen Igakkai Zasshi 2009; 46 (4) 348-351
19 Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A. A “new” congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred. Br J Haematol 1970; 19 (2) 179-192
20 Chung DW, Fujikawa K, McMullen BA, Davie EW. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry 1986; 25 (9) 2410-2417
21 McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human plasma prekallikrein: the presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry 1991; 30 (8) 2050-2056
22 Yu H, Anderson PJ, Freedman BI, Rich SS, Bowden DW. Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. Genomics 2000; 69 (2) 225-234
23 Govers-Riemslag JW, Smid M, Cooper JA , et al. The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost 2007; 5 (9) 1896-1903
24 Pantos A, Tsogas I, Paleos CM. Guanidinium group. Guanidinium group: a versatile moiety inducing transport and multicompartmentalization in complementary membranes. Biochim Biophys Acta 2008; 1778 (4) 811-823
25 Saito H, Goodnough LT, Soria J, Soria C, Aznar J, España F. Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. N Engl J Med 1981; 305 (16) 910-914
26 Currimbhoy Z, Vinciguerra V, Palakavongs P, Kuslansky P, Degnan TJ. Fletcher factor deficiency and myocardial infarction. Am J Clin Pathol 1976; 65 (6) 970-974
27 De Stefano V, Leone G, Teofili L , et al. Association of Graves' disease and prekallikrein congenital deficiency in a patient belonging to the first CRM+ prekallikrein-deficient Italian family. Thromb Res 1990; 60 (5) 397-404
28 Girolami A, Allemand E, Bertozzi I, Candeo N, Marun S, Girolami B. Thrombotic events in patients with congenital prekallikrein deficiency: a critical evaluation of all reported cases. Acta Haematol 2010; 123 (4) 210-214
29 Harris MG, Exner T, Rickard KA, Kronenberg H. Multiple cerebral thrombosis in Fletcher factor (prekallikrein) deficiency: a case report. Am J Hematol 1985; 19 (4) 387-393
30 Kyrle PA, Niessner H, Deutsch E, Lechner K, Korninger C, Mannhalter C. CRM+ severe Fletcher factor deficiency associated with Graves' disease. Haemostasis 1984; 14 (4) 302-306
31 Cichon S, Martin L, Hennies HC , et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 2006; 79 (6) 1098-1104
32 Zuraw BL, Christiansen SC. Pathogenesis and laboratory diagnosis of hereditary angioedema. Allergy Asthma Proc 2009; 30 (5) 487-492
33 Bork K, Wulff K, Meinke P, Wagner N, Hardt J, Witzke G. A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol 2011; 141 (1) 31-35
34 Gómez-Traseira C, López-Lera A, Drouet C , et al. Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: a multifactorial disease. J Allergy Clin Immunol 2013; 132 (4) 986-989 , e1–e5
35 Girolami A, Agostino D, Cliffton EE. The effect of ellagic acid on coagulation in vivo. Blood 1966; 27 (1) 93-102
36 Girolami A, Cliffton EE. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid. Thromb Diath Haemorrh 1967; 17 (1-2) 165-175
37 Lu X, Zhao W, Huang J , et al. Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case-control study. Hum Genet 2007; 121 (3-4) 327-335

The Old and the New in Prekallikrein Deficiency: Historical Context and a Family from Argentina with PK Deficiency due to a New Mutation (Arg541Gln) in Exon 14 Associated with a Common Polymorphysm (Asn124Ser) in Exon 5[*]

The Old and the New in Prekallikrein Deficiency: Historical Context and a Family from Argentina with PK Deficiency due to a New Mutation (Arg541Gln) in Exon 14 Associated with a Common Polymorphysm (Asn124Ser) in Exon 5^[*]